| Q38474124 | Assessing cognition after stroke. Who misses out? A systematic review |
| Q37204473 | Association of dementia with death after ischemic stroke: A two-year prospective study |
| Q52146533 | Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score. |
| Q30238668 | Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence? |
| Q34630980 | Dementia prediction for people with stroke in populations: is mild cognitive impairment a useful concept? |
| Q50713045 | Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study. |
| Q35606711 | Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors |
| Q34089381 | One-year survival of demented stroke patients: data from the Dijon Stroke Registry, France (1985-2008). |
| Q61902795 | Poststroke cognitive impairment and dementia: prevalence, diagnosis, and treatment |
| Q48159019 | Poststroke dementia is associated with recurrent ischaemic stroke |
| Q57821537 | Prevalence and factors associated with memory disturbance and dementia after acute ischemic stroke |
| Q42699966 | Risk factors associated with post-stroke dementia: a systematic review and meta-analysis |
| Q34956402 | Screening for cognitive decline following single known stroke using the Mini-Mental State Examination |
| Q58809486 | The influence of cognitive impairment on health-related quality of life in neurological disease |
| Q34039526 | Βeta-fibrinogen gene promoter A -455 allele associated with poor longterm survival among 55-71 years old Caucasian women in Finnish stroke cohort |